Clinical Trial Update: Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/Phase 3 trial evaluating second-line chemotherapy with S-1 in patients with S-1 refractory advanced gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Japan Clinical Cancer Research Organization | Conditions: Gastric Cancer | Phase 2, Phase 3 | Status: COMPLETED